Skip to main content

Announcement: COVID-19 impact on peer review

As a result of the significant disruption that is being caused by the COVID-19 pandemic we are very aware that many researchers will have difficulty in meeting the timelines associated with our peer review process during normal times. Please do let us know if you need additional time. Our systems will continue to remind you of the original timelines but we intend to be highly flexible at this time.

Featured article: Profound remission in Crohn’s disease requiring no further treatment for 3–23 years: a case series

Crohn’s disease (CD) is rising in incidence and has a high morbidity and increased mortality. It has been shown that there is an imbalance present in the gut microbiome (dysbiosis) in CD with a possible infective aetiology—Mycobacterium avium subsp. paratuberculosis (MAP) being the most proposed. The objective of this study was to report on the treatment and clinical outcomes of patients with CD in prolonged remission.

Gut Pathogens celebrates its 10th anniversary

Gut Pathogens launched in 2009 and its growth has followed the fast-paced developments of the field in the last ten years, from probiotics to bacterial genomics, to the rise of microbiome research. Dr. Niyaz Ahmed, Editor-in-Chief, tells us more about the success stories. 

We also look back on just some of the high quality work published by Gut Pathogens as we look forward to the next ten years

Articles

Latest Tweets

Blogs

Failed to load RSS feed.

Editor-in-Chief

Niyaz Ahmed, University of Hyderabad, India

Call for papers: cross-journal series

Spatial inequality

Spatial inequality, infectious diseases and disease control

Contribution of climate change to the spread of infectious diseases

Human migration, conflict and infectious diseases

Health policy and the management of antimicrobial resistance in LMICs

The microbiota–gut–brain axis

Aims and scope

Gut Pathogens publishes research on both biological and clinical aspects of the pathogens, commensals and functional microbiota of the gut, including probiotic bacteria and yeasts and their products. The journal also considers timely reports on the novel aspects of genomics, metagenomics, microbiota profiling and systems biology, as well as studies identifying new genome sequences of gut microbes.

Annual Journal Metrics